Advanced Liposarcoma
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Zanzalintinib Combined With Eribulin in Advanced Liposarcoma and Leiomyosarcoma (NCT06957431) | Washington University School of Medicine | 2025-10-22 |
Track Advanced Liposarcoma automatically
Every clearance here is in the API, with alerts when new ones post.